1-155238596-C-T

Variant summary

Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM5PP2PP3_StrongPP5

The NM_000157.4(GBA1):​c.509G>A​(p.Arg170His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000753 in 1,461,658 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R170C) has been classified as Pathogenic.

Frequency

Genomes: not found (cov: 29)
Exomes 𝑓: 0.0000075 ( 0 hom. )

Consequence

GBA1
NM_000157.4 missense

Scores

4
5
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1

Conservation

PhyloP100: 2.05

Publications

17 publications found
Variant links:
Genes affected
GBA1 (HGNC:4177): (glucosylceramidase beta 1) This gene encodes a lysosomal membrane protein that cleaves the beta-glucosidic linkage of glycosylceramide, an intermediate in glycolipid metabolism. Mutations in this gene cause Gaucher disease, a lysosomal storage disease characterized by an accumulation of glucocerebrosides. A related pseudogene is approximately 12 kb downstream of this gene on chromosome 1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2010]
GBA1 Gene-Disease associations (from GenCC):
  • Parkinson disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Gaucher disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, ClinGen
  • Gaucher disease perinatal lethal
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Laboratory for Molecular Medicine, Genomics England PanelApp
  • late-onset Parkinson disease
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Gaucher disease type I
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
  • Gaucher disease type II
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • Gaucher disease type III
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet
  • Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 10 ACMG points.

PM1
In a hotspot region, there are 10 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 2 uncertain in NM_000157.4
PM5
Other missense variant is known to change same aminoacid residue: Variant chr1-155238597-G-A is described in ClinVar as Pathogenic. ClinVar VariationId is 93453.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 94 curated pathogenic missense variants (we use a threshold of 10). The gene has 3 curated benign missense variants. Gene score misZ: 1.1739 (below the threshold of 3.09). Trascript score misZ: 2.2879 (below the threshold of 3.09). GenCC associations: The gene is linked to late-onset Parkinson disease, Gaucher disease perinatal lethal, Gaucher disease, Gaucher disease type I, Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome, Gaucher disease type II, Parkinson disease, Gaucher disease type III.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.966
PP5
Variant 1-155238596-C-T is Pathogenic according to our data. Variant chr1-155238596-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 813341.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000157.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GBA1
NM_000157.4
MANE Select
c.509G>Ap.Arg170His
missense
Exon 5 of 11NP_000148.2
GBA1
NM_001005741.3
c.509G>Ap.Arg170His
missense
Exon 6 of 12NP_001005741.1
GBA1
NM_001005742.3
c.509G>Ap.Arg170His
missense
Exon 6 of 12NP_001005742.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GBA1
ENST00000368373.8
TSL:1 MANE Select
c.509G>Ap.Arg170His
missense
Exon 5 of 11ENSP00000357357.3
GBA1
ENST00000327247.9
TSL:1
c.509G>Ap.Arg170His
missense
Exon 6 of 12ENSP00000314508.5
GBA1
ENST00000427500.7
TSL:2
c.362G>Ap.Arg121His
missense
Exon 4 of 10ENSP00000402577.2

Frequencies

GnomAD3 genomes
Cov.:
29
GnomAD2 exomes
AF:
0.0000239
AC:
6
AN:
251178
AF XY:
0.0000368
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000753
AC:
11
AN:
1461658
Hom.:
0
Cov.:
33
AF XY:
0.00000825
AC XY:
6
AN XY:
727142
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33472
American (AMR)
AF:
0.00
AC:
0
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000464
AC:
4
AN:
86246
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.00000630
AC:
7
AN:
1111832
Other (OTH)
AF:
0.00
AC:
0
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
29
Alfa
AF:
0.0000121
Hom.:
0
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Gaucher disease type II;C0268251:Gaucher disease type III;C1856476:Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;C1961835:Gaucher disease type I Pathogenic:1
Baylor Genetics
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Uncertain:1
Aug 03, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: GBA c.509G>A (p.Arg170His), also referred to as p.R131H, results in a non-conservative amino acid change located in the Glycosyl hydrolase family 30, TIM-barrel domain (IPR033453) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.4e-05 in 251178 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.509G>A has been reported in the literature in at least two individuals affected with Gaucher Disease (e.g. Liao_2014, Hassan_2018). At least one other variant causing a different missense change at the same amino acid residue has been classified as pathogenic in ClinVar (e.g. c.508C>T, p.Arg170Cys; ClinVar: 93453). These data do not allow any strong conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as uncertain significance.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Uncertain
0.023
T
BayesDel_noAF
Uncertain
0.0
CADD
Benign
21
DANN
Benign
0.95
DEOGEN2
Uncertain
0.72
D
Eigen
Benign
-0.28
Eigen_PC
Benign
-0.24
FATHMM_MKL
Uncertain
0.79
D
LIST_S2
Uncertain
0.90
D
M_CAP
Pathogenic
0.42
D
MetaRNN
Pathogenic
0.97
D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Benign
1.2
L
PhyloP100
2.1
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-1.0
N
REVEL
Pathogenic
0.85
Sift
Benign
0.53
T
Sift4G
Benign
0.43
T
Polyphen
0.63
P
Vest4
0.73
MutPred
0.89
Loss of phosphorylation at T173 (P = 0.0974)
MVP
0.90
MPC
0.95
ClinPred
0.21
T
GERP RS
3.5
Varity_R
0.47
gMVP
0.86
Mutation Taster
=2/98
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs80356763; hg19: chr1-155208387; API